Structure and Membership of the Writing Committee The members of the writing committee included clinicians specializing in interventional cardiology, general cardiology, internal medicine, cardiac surgery, and cardiac rehabilitation, as well as individuals with expertise in guideline development and performance measure development, implementation, and testing. The writing committee also included patient/con- sumer representatives and a payer representative. The writing committee had representation from the American Association of Cardiovascular and Pulmonary Rehabilitation, Mended Hearts, SCAI, and the Society for Thoracic Surgeons (STS). Nallamothu et al ACC/AHA/SCAI/AMA-PCPI/NCQA 2013 PCI Performance Measure 929 1.3. Disclosure of Relationships With Industry and Other Entities TheACC/AHATaskForceonPerformanceMeasuresmakesevery effort to avoid actual, potential, or perceived conflicts of interest that could arise as a result of relationships with industry or other entities (RWI). Detailed information on the ACC/AHA policy on RWI can be found at http://www.cardiosource.org/Science- And-Quality/Practice-Guidelines-and-Quality-Standards/ Relationships-With-Industry-Policy.aspx. All members of the writing committee, as well as those selected to serve as peer reviewers of this document, were required to dis- close all current relationships and those existing within the 12 months before the initiation of this writing effort. ACC/AHA policy also requires that the writing committee co-chairs and at least 50% of the writing committee have no relevant RWI. Table 1. 2013 ACC/AHA/SCAI/AMA-PCPI/NCQA Percutaneous Coronary Intervention Measurement Set Measure Description* 1. Comprehensive Documentation of Indications for PCI Percentage of patients aged 18 years for whom PCI is performed with comprehensive documentation of the procedure. This documentation includes, at a minimum, the following elements: 1. Priority (acute coronary syndrome, elective, urgent, emergency/salvage); 2. Presence and severity of angina symptoms (eg, Canadian Cardiovascular Society classification system); 3. Use of antianginal medical therapies within 2 weeks before the procedure, if any; 4. Presence, results, and timing of noninvasive stress test, fractional flow reserve, or intravascular ultrasound, if performed; and 5. 